Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787825 · ClinicalTrials.gov registry record · NA
Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease
A NA study, sponsored by Capso Vision.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT01787825 is a NA study that has completed, run by Capso Vision. The registered enrollment target is 121 participants.
The verdict
NCT01787825, a NA study, has completed, sponsored by Capso Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical findings involving the small bowel obtained with the Capso Vision Video Capsule Device to those results obtained with the PillCam SB2.
Interventions
- DEVICE PillCam SB2 capsule
- DEVICE CapsoCam SV-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787825
The ClinicalTrials.gov registry entry for NCT01787825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Capso Vision, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PillCam SB2 capsule is the first listed.
NCT01787825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01787825 about?
NCT01787825 is a clinical study titled "Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease". The purpose of this study is to compare the clinical findings involving the small bowel obtained with the Capso Vision Video Capsule Device to those results obtained with the PillCam SB2.
What is the current status of trial NCT01787825?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2012-05. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01787825?
The interventions under investigation include: PillCam SB2 capsule (DEVICE), CapsoCam SV-1 (DEVICE).
Who is sponsoring clinical trial NCT01787825?
This trial is sponsored by Capso Vision, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.